HHS awards $4.1 million to Hologic to develop better Zika blood screening test

Today, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response announced a $4.1 million agreement with Hologic, of Marlborough, Massachusetts, to advance the development of a blood screening test that will help detect the presence of Zika in the blood supply.  

This is the second blood screening test ASPR’s Biomedical Advanced Research and Development Authority (BARDA) is helping advance that may be used to test donated blood for Zika. In April, ASPR announced support of a clinical study of a Zika blood screening test developed by Roche Molecular Systems, of Branchburg, New Jersey, to confirm whether that test accurately detects the virus in donor blood.

“Accurate blood-screening tools are vital to protecting our nation’s blood supply from Zika. This test may provide another tool laboratories can use to identify infected blood donations to help ensure patients’ safety,” said Dr. Richard Hatchett, BARDA’s acting director. “At the same time, we are pursuing promising diagnostic tools, and vaccines to identify and prevent Zika virus infections.”

To continue reading this article…

Start your monthly or annual subscription to HIT Leaders & News today!

A monthly Standard subscription to all our regular news articles costs only $12.00 per month, or $144.00 for an annual Standard subscription.

Already a subscriber? Log in


BARDA, Biomedical Advanced Research and Development Authority, Department of Health and Human Services, Government Perspectives, HHS, Hologic, Zika, Zika virus


Please follow and ‘Like’ us


©2021 HIT Leaders and News, a GO Digital Media publication. All rights reserved.